Literature DB >> 20089081

Expression of cyclin D1 and p16 in psoriasis before and after phototherapy.

M Abou EL-Ela1, N Nagui, D Mahgoub, N El-Eishi, M Fawzy, A El-Tawdy, R Abdel Hay, L Rashed.   

Abstract

BACKGROUND: Psoriasis vulgaris (PV) is characterized by keratinocyte hyperproliferation. Altered expression of cell-cycle regulatory genes involved in the cyclin D1p16 INK4-pRb pathway may contribute to this epidermal hyperproliferation. AIM: To assess the expression of cyclin D1 and p16 in psoriasis, and to evaluate the effect of phototherapy on their expression.
METHODS: The study population comprised 25 patients with PV and 10 healthy controls. Patients were treated with 24 sessions of either narrowband ultraviolet (UV) B or psoralen UVA. Skin biopsies were taken from the affected skin of each patient before and after treatment, and from the healthy controls, to examine cyclin D1 and p16 expression.
RESULTS: Before phototherapy, the mean value of cyclin D1 concentration in patients was significantly greater than that in controls and the mean value of p16 concentration in patients was significantly lower than that in controls. Following treatment, we detected a significant decrease in cyclin D1 and a significant increase in p16.
CONCLUSION: Cyclin D1 upregulation and p16 downregulation may play a role in the pathogenesis of psoriasis. Normalization of the levels of both parameters may be a mechanism by which phototherapy induces remission in psoriasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089081     DOI: 10.1111/j.1365-2230.2009.03774.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

1.  Pituitary tumor transforming gene PTTG2 induces psoriasis by regulating vimentin and E-cadherin expression.

Authors:  Xiao-Bing Liu; Feng Li; Ya-Qin Li; Fan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 2.  Phototherapy in psoriasis: a review of mechanisms of action.

Authors:  Tami Wong; Leon Hsu; Wilson Liao
Journal:  J Cutan Med Surg       Date:  2013 Jan-Feb       Impact factor: 2.092

3.  Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.

Authors:  Immanuel Lerner; Eyal Zcharia; Tzahi Neuman; Esther Hermano; Ariel M Rubinstein; Israel Vlodavsky; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2013-10-30       Impact factor: 9.261

4.  Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis.

Authors:  Engin Sezer; Almut Böer-Auer; Emel Cetin; Fatma Tokat; Emel Durmaz; Sedef Sahin; Umit Ince
Journal:  Dermatol Pract Concept       Date:  2015-07-31

5.  Expression of p16 in psoriasis and chronic spongiotic dermatitis.

Authors:  Viktoryia Kazlouskaya; Elina Shustef; Elen Blochin
Journal:  Indian Dermatol Online J       Date:  2015 Jul-Aug

6.  Differential expression of cyclin D1, Ki‑67, pRb, and p53 in psoriatic skin lesions and normal skin.

Authors:  Sung Ae Kim; Young Wook Ryu; Jun Il Kwon; Mi Sun Choe; Jin Woong Jung; Jae We Cho
Journal:  Mol Med Rep       Date:  2017-11-08       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.